Cargando…
Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy
Congenital generalized lipodystrophy type 2 is a serious multisystem disorder with limited treatment options. It is caused by mutations affecting the BSCL2 gene, which encodes the protein seipin. Patients with congenital generalized lipodystrophy type 2 lack both metabolic and mechanical adipose tis...
Autores principales: | Sommer, Nadine, Roumane, Ahlima, Han, Weiping, Delibegović, Mirela, Rochford, Justin J., Mcilroy, George D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589143/ https://www.ncbi.nlm.nih.gov/pubmed/36320417 http://dx.doi.org/10.1016/j.omtm.2022.09.014 |
Ejemplares similares
-
Bscl2 Deficiency Does Not Directly Impair the Innate Immune Response in a Murine Model of Generalized Lipodystrophy
por: Roumane, Ahlima, et al.
Publicado: (2021) -
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
por: Mcilroy, George D., et al.
Publicado: (2020) -
Oligomers of the lipodystrophy protein seipin may co-ordinate GPAT3 and AGPAT2 enzymes to facilitate adipocyte differentiation
por: Sim, M. F. Michelle, et al.
Publicado: (2020) -
Female adipose tissue-specific Bscl2 knockout mice develop only moderate metabolic dysfunction when housed at thermoneutrality and fed a high-fat diet
por: Mcilroy, George D., et al.
Publicado: (2018) -
Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease
por: Mcilroy, George D., et al.
Publicado: (2018)